Newsletters

[alexed]

Bell2Bell.com - http://www.Bell2Bell.com

Have a look at this company for market week beginning
Monday, December 18, 2000.


New publicly traded company
"new generation acrylic"
"revolutionary company"


ThermoElastic Technologies, Inc.
Ticker: TMRO
Exchange: OTCBB
Share Price Range: .20 - .25
Web Site: http://www.thermoelastictech.com/



About ThermoElastic Technologies, Inc.


ThermoElastic Technologies, Inc. (OTC Bulletin Board: TMRO), a
revolutionary company that could change more than 60 industries forever.
ThermoElastic Technologies develops and markets a new generation acrylic,
known as Biocompatible Intraoral Thermo Elastic Material. This new plastic
is amazingly versatile and is applicable to several multimillion dollar
products. When heated in warm water, the acrylic's shape can be
effortlessly molded into anything from dentures to bicycle seats.
The power of this patented technology lies in the controlling mixture of
two liquid monomers acting as a softener and a hardener. For example,
ThermoElastic's product allows for the first major change in denture
design in more than 200 years. The overall market for dental products
incorporating this kind of acrylics is expected to rise 270 percent! With
more than 60 applications in the dental industry alone, ThermoElastic is
poised to grab a huge portion of this growth.
Taking the fast route to marketplace dominance in the billion-dollar
dental industry, ThermoElastic has pending agreements with dental supply
distributors that could thrust its fiscal 2000 sales into high gear.
Industries that ThermoElastic is targeting include eyeglasses, sports
equipment, orthotics, and hearing aids.


ThermoElastic Technologies, Inc. recently announced that it has signed an
agreement with Garreco, Inc. to act as marketing agent for ThermoElastic
Technologies, Inc. (TTI) commencing with deliveries on the recently
announced agreement with Zahn Dental Company, Inc.
Under the terms of the agreement, Garreco will act as the point of contact
and handle all the packaging, labeling and delivery of TTI's dental
products to dental dealers, with rights of first refusal for other
industry applications. In this capacity, Garreco will be the point of sale
with all proceeds less associated costs passed on to TTI. Based on TTI's
ability to meet its growth projections, this contract could represent
gross sales of up to $2,865,000 in the 12-month period following
commencement of sales to Zahn Dental Company, Inc.




ThermoElastic Technologies, Inc. is currently seeking uses for this
technology inside and outside of the dental world. They are currently
pursuing the following opportunities:


*Orthotics- Orthoses are shoe inserts.
*Rigid Orthotics- they are designed to control foot function and are made
of a stiff material such as plastic.
*Soft Orthotics- They are designed to absorb shock and aid in increasing
foot comfort.
*Splints- The thermoelastic qualities of BITEM are particularly suitable
for the creation of low-cost splints.
*Medical Prostheses- The fabrication of prosthetic and orthopedic devices
from BITEM adds a new dimension to the practice of Prosthetics and
Orthotics.
*Braces- Prosthetics, orthopedic braces and artificial limbs are a billion
dollar a year industry in the United States.
*Custom Furniture- The BITEM technology is now being used in the
architectural process to customize a new artistically designed line of
contemporary furniture.
*Specialized Glasses- With BITEM, the optical industry is able to
customize the nose and ear parts of the frames of all their clients.
*Hearing Aids- Audiologists are always looking for new technologies and
materials to improve upon the fit and service of the hearing aids for
their patients.
*Aids to daily living- Rehabilitation centers, physical and occupational
therapists.
*Sports Equipment- In all sports, there is a need to customize the
equipment used in that sport and to fit each participant's particular
requirements.
*Customized Instrumentation- Any trade that requires or uses specialized
tools could be a candidate for this a new material.



Latest press Releases-
November 27 - ThermoElastic Signs Agreement With New Marketing Firm,
Garreco, Inc.
The Officers & Directors of ThermoElastic Technologies, Inc. include:

Officers and Directors
FRED J. HEAPS, Chief Executive Officer, Director
KENNETH B. LIEBSCHER, President, Director
BERNARD TEITELBAUM, Vice President Sales & Marketing, Secretary
DANIEL WISEMAN, Chief Financial Officer
DENNIS EPSTEIN, Chairman of the Board, Director
DR. LORNE BERMAN, Director
DR. STEPHEN RIVERS, Director
DR. ILA BERMAN, Director
DR. IZCHAK BARZILAY, Director
BONNIE WALTON, Director



**********************************************************************


CONCLUSION
Over the next 12 months, ThermoElastic plans to market and distribute
dental applications in the United States and internationally. This report
would be too long if we had to publish every detail about ThermoElastic
Technologies, Inc. we highly recommend that you go to their
web site to learn more.
Products Overview-
http://www.thermoelastictech.com/products/tech_overview.html
Bitem - http://www.thermoelastictech.com/products/bitem_intro.html
Future Products - http://www.thermoelastictech.com/products/future.html
Officers and Directors-
http://www.thermoelastictech.com/corporate/officers.html




Happy Trading!
The Staff



*************************************************************
Add ThermoElastic Technologies, Inc. (TMRO) to your FREE portfolio tracker.
Do you have a FREE news and price alert portfolio? If not, open one here-
http://www.bell2bell.newsalert.com/bin/verify?Subscribe=1
*************************************************************



**********************************************************************




Disclaimer and SEC Compliance - The newsletter is provided by Value Plus
Marketing, an electronic broadcaster and publisher of this newsletter, is
here after referred to as "the company". The company
received compensation in the form of fifty thousand free trading shares
of ThermoElastic Technologies, Inc. (TMRO) from a third party shareholder
and at which time the company still holds all fifty thousand. The company
is also expecting to receive fifty thousand restricted 144 shares from
ThermoElastic Technologies, Inc.
Because the company is receiving compensation for its services, there is
an inherent conflict of interest in the company statements and opinions
and such statements and opinions cannot be considered independent. The
company reserves the right to trade in securities mentioned herein, and
may make purchases or sales in such
securities featured within our newsletter reports only after the initial
advertising coverage contracted for has expired which will be considered
as no less than seven days from the date published within the top portion
of this report. The information contained in this publication is for
informational purposes only, and not to be construed as an offer to sell
or solicitation of an offer to buy any security. The company makes no
representation or warranty relating to the validity of the facts presented
nor does the company represent or warrant that all material facts
necessary to make an investment decision are presented above. All
statements of opinions (Conclusion) are those of the company. For the rest
of this report the company relies exclusively on information gathered from
the client, or public filings and news releases on featured client.
Investors should use the information contained in this publication as a
starting point for conducting additional research on the featured
companies in order to allow the investor to form his or her own opinion
regarding the featured companies. Factual statements contained in this
publication are made as of the date stated and they are subject to change
without notice. The company is not a registered investment adviser, broker
or a dealer. Investment in the clients reviewed is speculative and
a high-risk and may result in the loss of some or all of any investment
made in the client. Any statements that express or involve discussions
with respect to predictions, expectations, beliefs, plans, projections,
objectives, goals, assumptions or future events or performance are not
statements of historical fact and may be "forward looking statements."
Forward looking statements are based on expectations, estimates and
projections at the time the statements are made that involve a number of
risks and uncertainties which could cause actual results or events to
differ materially from those presently anticipated. Forward looking
statements in this action may be identified through the use of words such
as "projects", "foresee", "expects'","will," "anticipates," "estimates,"
"believes," "feel," or that by statements indicating certain actions
"may," "could," "should," or "might" occur.